Corient Private Wealth LP Sells 91,743 Shares of Omega Healthcare Investors, Inc. $OHI

Corient Private Wealth LP trimmed its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 23.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 298,808 shares of the real estate investment trust's stock after selling 91,743 shares during the quarter. Corient Private Wealth LP owned about 0.10% of Omega Healthcare Investors worth $14,247,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Ascentis Independent Advisors bought a new stake in Omega Healthcare Investors in the 1st quarter worth about $35,000. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new position in Omega Healthcare Investors in the 4th quarter worth $37,000. Rothschild Investment LLC lifted its position in Omega Healthcare Investors by 283.7% during the fourth quarter. Rothschild Investment LLC now owns 944 shares of the real estate investment trust's stock valued at $42,000 after purchasing an additional 698 shares in the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in Omega Healthcare Investors by 53.3% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 906 shares of the real estate investment trust's stock valued at $43,000 after purchasing an additional 315 shares during the period. Finally, Larson Financial Group LLC grew its holdings in Omega Healthcare Investors by 345.2% during the fourth quarter. Larson Financial Group LLC now owns 984 shares of the real estate investment trust's stock valued at $44,000 after purchasing an additional 763 shares during the period. 65.25% of the stock is owned by hedge funds and other institutional investors.

Omega Healthcare Investors Price Performance

Shares of OHI opened at $47.07 on Wednesday. The firm has a market cap of $14.26 billion, a P/E ratio of 16.81, a price-to-earnings-growth ratio of 1.91 and a beta of 0.58. Omega Healthcare Investors, Inc. has a 1 year low of $39.26 and a 1 year high of $52.39. The company has a 50 day simple moving average of $48.06 and a two-hundred day simple moving average of $47.09.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 EPS for the quarter, topping the consensus estimate of $0.51 by $0.68. The firm had revenue of $328.25 million for the quarter, compared to the consensus estimate of $266.97 million. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The company's quarterly revenue was up 16.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.77 earnings per share. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. On average, sell-side analysts anticipate that Omega Healthcare Investors, Inc. will post 3.12 earnings per share for the current year.

Omega Healthcare Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Monday, August 3rd were given a dividend of $0.68 per share. The ex-dividend date was Monday, August 3rd. This is a positive change from Omega Healthcare Investors's previous quarterly dividend of $0.67. This represents a $2.72 dividend on an annualized basis and a dividend yield of 5.8%. Omega Healthcare Investors's dividend payout ratio (DPR) is 97.14%.

Analysts Set New Price Targets

Several research firms have recently commented on OHI. Mizuho raised their price objective on Omega Healthcare Investors from $45.00 to $46.00 and gave the stock a "neutral" rating in a research note on Monday, August 31st. Scotiabank cut their price objective on Omega Healthcare Investors from $50.00 to $47.00 and set a "sector perform" rating for the company in a research note on Thursday, June 18th. Raymond James Financial began coverage on shares of Omega Healthcare Investors in a report on Tuesday, June 16th. They issued an "outperform" rating and a $50.00 target price for the company. UBS Group set a $47.00 target price on shares of Omega Healthcare Investors in a research note on Thursday, June 18th. Finally, Cantor Fitzgerald raised their target price on shares of Omega Healthcare Investors from $52.00 to $56.00 and gave the stock an "overweight" rating in a research note on Friday, July 31st. Six analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $49.50.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc NYSE: OHI is a real estate investment trust focused on the healthcare sector. The company owns and leases healthcare-related real estate, with an emphasis on facilities that provide long-term and post-acute care.

Omega's portfolio is primarily made up of skilled nursing facilities and assisted living facilities. It generally leases these properties to healthcare operators under long-term, often triple-net lease arrangements, under which tenants are typically responsible for property-level expenses such as maintenance, insurance and taxes.

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.